Lack of any relationship between chemotherapy toxicity in non-small cell lung cancer cases and polymorphisms in XRCC1 codon 399 or XPD codon 751. [electronic resource]
Producer: 20110930Description: 739-42 p. digitalISSN:- 2476-762X
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Large Cell -- drug therapy
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Carcinoma, Squamous Cell -- drug therapy
- Cisplatin -- administration & dosage
- Codon -- genetics
- DNA, Neoplasm -- genetics
- DNA-Binding Proteins -- genetics
- Deoxycytidine -- administration & dosage
- Docetaxel
- Female
- Follow-Up Studies
- Genotype
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Staging
- Paclitaxel -- administration & dosage
- Polymerase Chain Reaction
- Polymorphism, Restriction Fragment Length
- Polymorphism, Single Nucleotide -- genetics
- Survival Rate
- Taxoids -- administration & dosage
- Treatment Outcome
- X-ray Repair Cross Complementing Protein 1
- Xeroderma Pigmentosum Group D Protein -- genetics
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.